Abstract
A Randomized Trial of Unruptured Brain AVMs is a multidisciplinary international randomized controlled clinical trial including 800 adult patients with the diagnosis of an unruptured brain AVM. Patients willing to participate are randomly assigned to either best possible invasive therapy (endovascular, neurosurgical, and/or radiation therapy) or medical management without intervention. The study protocol does not modify any routine treatment strategies in either arm. Patients will be followed for a minimum of 5 years and a maximum of 10 years from randomization.
The primary outcome measure is the composite endpoint of death from any cause or stroke (clinically symptomatic hemorrhage or infarction confirmed by imaging). The secondary outcome measure is long-term clinical status by Rankin Scale, NIHSS, SF-36, and EuroQol.
Patient enrollment was successfully started in 2007. Participating sites currently include multidisciplinary treatment centers in North and South America, Australasia, and Europe (including Australia, Austria, Brazil, Canada, Finland, France, Germany, Italy, Netherlands, Spain, South Korea, Switzerland, UK, and the USA).
The trial is sponsored and monitored by the US NIH/NINDS (NCT00389181).
Conflicts of interest statement We declare that we have no conflict of interest.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Castel JP, Kantor G (2001) Postoperative morbidity and mortality after microsurgical exclusion of cerebral arteriovenous malformations. Current data and analysis of recent literature. Neurochirurgie 47:369–383
Stapf C, Mohr JP, Choi JH, Mast H (2006) Invasive treatment of unruptured brain arteriovenous malformations is experimental therapy. Curr Opin Neurol 19:63–68
Pollock BE, Brown RD (2006) Use of modified Rankin Scale to assess outcome after arteriovenous malformation surgery. Neurology 67:1630–1634
Flickinger JC, Kondziolka D, Lunsford LD, Pollock BE, Yamamoto M, Gorman DA, Schomberg PJ, Sneed P, Larson D, Smith V, McDermott MW, Miyawaki L, Chilton J, Morantz RA, Young B, Jokura H, Liscak R (1999) A multi-institutional analysis of complication outcomes after arteriovenous malformation radiosurgery. Int J Radiat Oncol Biol Phys 44:67–74
Al-Shahi R, Bhattacharya JJ, Currie DG, Papanastassiou V, Ritchie V, Roberts RC, Sellar RJ, Warlow CP, Scottish Intracranial Vascular Malformation Study Collaborators (2003) Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish intracranial vascular malformation study (SIVMS). Stroke 34: 1163–1169
Brown RD Jr, Wiebers DO, Torner JC, O’Fallon WM (1996) Incidence and prevalence of intracranial vascular malformations in Olmsted County, Minnesota, 1965 to 1992. Neurology 46:949–952
Stapf C, Mast H, Sciacca RR, Berenstein A, Nelson PK, Gobin YP, Pile-Spellman J, Mohr JP (2003) The New York Islands AVM study: design, study progress, and initial results. Stroke 34:e29–e33
Halim AX, Johnston SC, Singh V, McCulloch CE, Bennett JP, Achrol AS, Sidney S, Young WL (2004) Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke 35:1697–1702
Stapf C, Mast H, Sciacca RR, Choi JH, Khaw AV, Connolly ES, Pile-Spellman J, Mohr JP (2006) Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology 66:1350–1355
Laakso A, Dashti R, Seppänen J, Juvela S, Väärt K, Niemelä M, Sankila R, Hernesniemi JA (2008) Long-term excess mortality in 623 patients with brain arteriovenous malformations. Neurosurgery 63:244–253
Wedderburn CJ, van Beijnum J, Bhattacharya JJ, Counsell CE, Papanastassiou V, Ritchie V, Roberts RC, Sellar RJ, Warlow CP, Al-Shahi Salman R, Collaborators SIVMS (2008) Outcome after interventional or conservative management of unruptured brain arteriovenous malformations: a prospective, population-based cohort study. Lancet Neurol 7:223–230
Al-Shahi R, Warlow CP (2006) Interventions for treating brain arteriovenous malformations in adults. Cochrane Database Syst Rev CD003436
Brown RD Jr (2008) Unruptured brain AVMs: to treat or not to treat. Lancet Neurol 7:195–196
Davis SM, Donnan GA (2007) Unruptured brain arteriovenous malformations: another asymptomatic conundrum. Stroke 38:3312
Acknowledgments
A randomized trial of Unruptured Brain AVMs (ARUBA) is funded by NIH/NINDS grants U01 NS051483 (PI: J.P. Mohr) and U01 NS051566 (PI: A.J. Moskowitz). The study is internationally registered as NCT00389181 and ISRCTN44013133. CERVCO (French Reference Center of Rare Vascular Diseases of the Brain and Eye, www.cervco.fr) is supported by public funds by the French Ministry of Health.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2010 Springer-Verlag/Wien
About this chapter
Cite this chapter
Stapf, C. (2010). The Rationale Behind “A Randomized Trial of Unruptured Brain AVMs” (ARUBA). In: Surgical Management of Cerebrovascular Disease. Acta Neurochirurgica Supplementum, vol 107. Springer, Vienna. https://doi.org/10.1007/978-3-211-99373-6_13
Download citation
DOI: https://doi.org/10.1007/978-3-211-99373-6_13
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-99372-9
Online ISBN: 978-3-211-99373-6
eBook Packages: MedicineMedicine (R0)